Add on Lacosamide Versus High Dose Monotherapy

Phase 3 Completed NCT01345058

Condition	Epilepsy
Phase	Phase 3
Sponsor	Brigham and Women's Hospital
Status	Completed
Enrollment	56 participants
Interventions	lacosamide, levetiracetam
Start date	Aug 1, 2011
Completion date	Feb 15, 2014
Results posted	Apr 25, 2017

Summary

This is a study to determine whether a combination of low dose lacosamide and levetiracetam is more effective than high dose levetiracetam in patients who have failed low dose levetiracetam.

Percentage of Participants Achieving Six Month Seizure Freedom

6 Months · percentage of participants

Lacosamide + Low-Dose Levetiracetam	47.4 percentage of participants
Control Group (High-Dose Levetiracetam)	41.7 percentage of participants

p-value	0.49
Hazard Ratio (HR)	0.76 (95% CI 0.35–1.65)

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

Safety and Efficacy of tPBM for Epileptiform Activity in Autism — Richard Frye
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Th — SK Life Science, Inc.
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines — Rutgers, The State University of New Jersey
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagno — University of Virginia
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or — Takeda
Maintenance TMS in Treatment Resistant Depression — Austin Messner

All trials

This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.

English 한국어 日本語中文 Русский